文献速递免疫规划传染病防控与疫情报告

含LTB或鞭毛蛋白的H5N1病毒样颗粒增强小鼠肌内和口服免疫保护

Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and oral immunization of mice.
PubMed 文献 · Vaccine · 2018-08-30

研究构建含H5N1 HA、NA、M1及膜锚定LTB或Flic的病毒样颗粒(VLP),比较小鼠肌内或口服免疫后的免疫应答与攻毒保护。含LTB或Flic的VLP诱导更强体液和细胞免疫;肌内免疫无论是否含佐剂蛋白均保护同源和异源H5N1攻毒;口服LTB-或Flic-VLP提供实质保护,而不含佐剂VLP口服组全部死亡。

要点

  • 含LTB或Flic的VLP免疫小鼠体液和细胞免疫应答高于不含LTB或Flic的H5N1 VLP。
  • 肌内免疫含或不含LTB/Flic的VLP均保护同源和异源H5N1 lethal challenge。
  • 口服LTB-或Flic-VLP对同源和异源H5N1攻毒提供实质保护,不含佐剂VLP口服组全部死亡。

核心结论

  • 在VLP疫苗中加入LTB或Flic等免疫刺激蛋白可能通过诱导更高体液和细胞免疫应答及改善跨分支保护,成为控制当前H5N1 HPAI疫情的有前景新方法。

研究设计与样本

  • 研究生成由H5N1病毒HA、NA、M1蛋白及膜锚定大肠杆菌热不稳定肠毒素B亚单位蛋白(LTB)或Toll样受体5配体鞭毛蛋白(Flic)组成的VLP,并以小鼠肌内或口服免疫后评估免疫应答与致死性攻毒保护。

主要发现

  • 肌内或口服免疫含LTB或Flic的VLP小鼠产生的体液和细胞免疫应答高于接种不含LTB或Flic的H5N1 VLP的小鼠。
  • 肌内免疫VLP保护小鼠免受同源或异源H5N1病毒致死性攻毒,无论VLP是否额外包含LTB或Flic。
  • 口服LTB-或Flic-VLP免疫对同源和异源H5N1流感病毒致死性攻毒提供实质保护,而口服不含LTB和Flic的VLP小鼠全部死于感染。
  • 口服LTB-或Flic-VLP免疫小鼠的病毒特异性IgG滴度比接种不含LTB或Flic的H5N1-VLP小鼠高10倍。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We previously demonstrated that intramuscular immunization with virus-like particles (VLPs) composed of the haemagglutinin (HA), neuraminidase (NA), and matrix (M1) proteins of A/meerkat/Shanghai/SH-1/2012 (clade 2.3.2.1) protected mice from lethal challenge with viruses from other H5 HPAI clades. The inclusion of additional proteins that can serve as immunological adjuvants in VLPs may enhance adaptive immune responses following vaccination, and oral vaccines may represent the safest choice. Here, we report the generation of H5N1 VLPs composed of the viral HA, NA, and M1 proteins and membrane-anchored forms of the Escherichia coli heat-labile enterotoxin B subunit protein (LTB) or the Toll-like receptor 5 ligand flagellin (Flic). Mice intramuscularly or orally immunized with VLPs containing LTB or Flic generated greater humoural and cellular immune responses than those administered H5N1 VLPs without LTB or Flic. Intramuscular immunization with VLPs protected mice from lethal challenge with homologous or heterologous H5N1 viruses irrespective of whether the VLPs additionally included LTB or Flic. In contrast, oral immunization of mice with LTB- or Flic-VLPs conferred substantial protection against lethal challenge with both homologous and heterologous H5N1 influenza viruses, whereas mice immunized orally with VLPs lacking LTB and Flic universally succumbed to infection. Mice immunized orally with LTB- or Flic-VLPs showed 10-fold higher virus-specific IgG titres than mice immunized with H5N1-VLPs lacking LTB or Flic. Collectively, these results indicate that the inclusion of immunostimulatory proteins, such as LTB and Flic, in VLP-based vaccines may represent a promising new approach for the control of current H5N1 HPAI outbreaks by eliciting higher humoural and cellular immune responses and conferring improved cross-clade protection.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ren Z, Zhao Y, Liu J, et al. Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and oral immunization of mice. Vaccine. 2018. PMID: 30172635. doi:10.1016/j.vaccine.2018.08.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。